The Bio-Neuroscience meeting takes place in Amsterdam, the Netherlands on February 24-26. The meeting brings together leading CEOs, investors, executives and industry leaders in neuroscience drug development.
With long experience in supporting pharma clients in drug discovery, with a particular focus on target and lead discovery in neurobiology, Cellectricon is looking forward to taking part in the meeting. If you are interested in learning more about Cellectricon’s neuroscience drug discovery services, reach out to setup a meeting with Paul Karila, our CBO, while in Amsterdam.
Paul Karila
CBO
Meet us at Bio-Neuroscience!
We are looking forward to taking part in this year’s meeting and for the opportunity to introduce our drug discovery services, and in particular our newly launched Neurotoxicity Testing Services, to prospective new partners. Get in touch if you are interested in setting up a meeting!